Details
Title Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry
IRB MONT1316
CC 16-688
Hospital Main Campus
Disease Brain
Description
To further understand performance and utilization of NBS in current standard of care, post-market multi-center registry called LAANTERN (Laser Ablation of Abnormal Neurological Tissue using Robotic Neuroblate system) is designed to collect baseline, procedural and follow-up data on patients that are already scheduled to be treated with NBS in observational manner for publication purposes.
Inclusion Criteria
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient who is to undergo thermal therapy by the NeuroBlate®. System for treatment of their neurological disorder
Exclusion Criteria
- Patient who is, or is expected to be inaccessible for follow-up
- Patient meets any exclusion criteria required by local law (e.g. age)
- Other concurrent medical or other condition (chronic or acute in nature) that in the opinion of the investigator may prevent participation or otherwise render patient ineligibility for the study